High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluorescence imaging, and other visualization processes to get quantitative data from cell populations.
Highlights
The global High Content Screening market was valued at US$ 614.5 million in 2022 and is anticipated to reach US$ 993.8 million by 2029, witnessing a CAGR of 8.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The high-content screening market is anticipated to witness significant growth during the forecast period, owing to the ability of HCS to study several parameters in a complex biological system simultaneously.
Report Scope
This report aims to provide a comprehensive presentation of the global market for High Content Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High Content Screening.
The High Content Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global High Content Screening market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the High Content Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Molecular Devices
Thermo Fisher Scientific
PerkinElmer Inc.
Becton
GE Healthcare
Dickinson and Company
Merck KGaA
Cell Signaling Technology
Thorlabs, Inc.
Genedata AG
Yokogawa Electric Corporation
Segment by Type
Consumables
Microplates
Instruments
Software and Service
Segment by Application
Primary & Secondary Screening
Compound Profiling
Target Identification & Validation
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of High Content Screening companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High Content Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Consumables
1.2.3 Microplates
1.2.4 Instruments
1.2.5 Software and Service
1.3 Market by Application
1.3.1 Global High Content Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Primary & Secondary Screening
1.3.3 Compound Profiling
1.3.4 Target Identification & Validation
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global High Content Screening Market Perspective (2018-2029)
2.2 High Content Screening Growth Trends by Region
2.2.1 Global High Content Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 High Content Screening Historic Market Size by Region (2018-2023)
2.2.3 High Content Screening Forecasted Market Size by Region (2024-2029)
2.3 High Content Screening Market Dynamics
2.3.1 High Content Screening Industry Trends
2.3.2 High Content Screening Market Drivers
2.3.3 High Content Screening Market Challenges
2.3.4 High Content Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top High Content Screening Players by Revenue
3.1.1 Global Top High Content Screening Players by Revenue (2018-2023)
3.1.2 Global High Content Screening Revenue Market Share by Players (2018-2023)
3.2 Global High Content Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by High Content Screening Revenue
3.4 Global High Content Screening Market Concentration Ratio
3.4.1 Global High Content Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High Content Screening Revenue in 2022
3.5 High Content Screening Key Players Head office and Area Served
3.6 Key Players High Content Screening Product Solution and Service
3.7 Date of Enter into High Content Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 High Content Screening Breakdown Data by Type
4.1 Global High Content Screening Historic Market Size by Type (2018-2023)
4.2 Global High Content Screening Forecasted Market Size by Type (2024-2029)
5 High Content Screening Breakdown Data by Application
5.1 Global High Content Screening Historic Market Size by Application (2018-2023)
5.2 Global High Content Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America High Content Screening Market Size (2018-2029)
6.2 North America High Content Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America High Content Screening Market Size by Country (2018-2023)
6.4 North America High Content Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe High Content Screening Market Size (2018-2029)
7.2 Europe High Content Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe High Content Screening Market Size by Country (2018-2023)
7.4 Europe High Content Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific High Content Screening Market Size (2018-2029)
8.2 Asia-Pacific High Content Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific High Content Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific High Content Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America High Content Screening Market Size (2018-2029)
9.2 Latin America High Content Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America High Content Screening Market Size by Country (2018-2023)
9.4 Latin America High Content Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High Content Screening Market Size (2018-2029)
10.2 Middle East & Africa High Content Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa High Content Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa High Content Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Molecular Devices
11.1.1 Molecular Devices Company Detail
11.1.2 Molecular Devices Business Overview
11.1.3 Molecular Devices High Content Screening Introduction
11.1.4 Molecular Devices Revenue in High Content Screening Business (2018-2023)
11.1.5 Molecular Devices Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific High Content Screening Introduction
11.2.4 Thermo Fisher Scientific Revenue in High Content Screening Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 PerkinElmer Inc.
11.3.1 PerkinElmer Inc. Company Detail
11.3.2 PerkinElmer Inc. Business Overview
11.3.3 PerkinElmer Inc. High Content Screening Introduction
11.3.4 PerkinElmer Inc. Revenue in High Content Screening Business (2018-2023)
11.3.5 PerkinElmer Inc. Recent Development
11.4 Becton
11.4.1 Becton Company Detail
11.4.2 Becton Business Overview
11.4.3 Becton High Content Screening Introduction
11.4.4 Becton Revenue in High Content Screening Business (2018-2023)
11.4.5 Becton Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Detail
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare High Content Screening Introduction
11.5.4 GE Healthcare Revenue in High Content Screening Business (2018-2023)
11.5.5 GE Healthcare Recent Development
11.6 Dickinson and Company
11.6.1 Dickinson and Company Company Detail
11.6.2 Dickinson and Company Business Overview
11.6.3 Dickinson and Company High Content Screening Introduction
11.6.4 Dickinson and Company Revenue in High Content Screening Business (2018-2023)
11.6.5 Dickinson and Company Recent Development
11.7 Merck KGaA
11.7.1 Merck KGaA Company Detail
11.7.2 Merck KGaA Business Overview
11.7.3 Merck KGaA High Content Screening Introduction
11.7.4 Merck KGaA Revenue in High Content Screening Business (2018-2023)
11.7.5 Merck KGaA Recent Development
11.8 Cell Signaling Technology
11.8.1 Cell Signaling Technology Company Detail
11.8.2 Cell Signaling Technology Business Overview
11.8.3 Cell Signaling Technology High Content Screening Introduction
11.8.4 Cell Signaling Technology Revenue in High Content Screening Business (2018-2023)
11.8.5 Cell Signaling Technology Recent Development
11.9 Thorlabs, Inc.
11.9.1 Thorlabs, Inc. Company Detail
11.9.2 Thorlabs, Inc. Business Overview
11.9.3 Thorlabs, Inc. High Content Screening Introduction
11.9.4 Thorlabs, Inc. Revenue in High Content Screening Business (2018-2023)
11.9.5 Thorlabs, Inc. Recent Development
11.10 Genedata AG
11.10.1 Genedata AG Company Detail
11.10.2 Genedata AG Business Overview
11.10.3 Genedata AG High Content Screening Introduction
11.10.4 Genedata AG Revenue in High Content Screening Business (2018-2023)
11.10.5 Genedata AG Recent Development
11.11 Yokogawa Electric Corporation
11.11.1 Yokogawa Electric Corporation Company Detail
11.11.2 Yokogawa Electric Corporation Business Overview
11.11.3 Yokogawa Electric Corporation High Content Screening Introduction
11.11.4 Yokogawa Electric Corporation Revenue in High Content Screening Business (2018-2023)
11.11.5 Yokogawa Electric Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Molecular Devices
Thermo Fisher Scientific
PerkinElmer Inc.
Becton
GE Healthcare
Dickinson and Company
Merck KGaA
Cell Signaling Technology
Thorlabs, Inc.
Genedata AG
Yokogawa Electric Corporation
听
听
*If Applicable.
